CAMBRIDGE IP, INC. – Trademark Portfolio
Entity Type: 03
CAMBRIDGE IP, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 37 (Building & Construction) — 4 filings in this category. The portfolio also extends into Class 36 (Insurance & Financial) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include ONEC1TY, MINDFUL HEALTHY LIVING, MADE EASY, and ONEC1TY COLLABORATION INNOVATION TECHNOLOGY YOU. The owner is based in DALLAS, TX.
8383 PRESTON CENTER PLAZA DR., 5TH FL.
DALLAS, TX 75225
Showing of trademarks Trademarks
Trademark Classifications
CAMBRIDGE IP, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Insurance; financial affairs; monetary affairs; real estate affairs
Education; providing of training; entertainment; sporting and cultural activities
Frequently Asked Questions
How many trademarks does CAMBRIDGE IP, INC. have?
CAMBRIDGE IP, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending.
What trademark classes does CAMBRIDGE IP, INC. file in?
CAMBRIDGE IP, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 37 (Building & Construction), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment). Class 37 covers building construction; repair; installation services.
What are CAMBRIDGE IP, INC.'s most well-known trademarks?
CAMBRIDGE IP, INC.'s registered trademark portfolio includes well-known marks such as ONEC1TY, MINDFUL HEALTHY LIVING, MADE EASY, and ONEC1TY COLLABORATION INNOVATION TECHNOLOGY YOU. These are among 4 currently registered trademarks in the portfolio.
What is CAMBRIDGE IP, INC.'s trademark registration success rate?
CAMBRIDGE IP, INC. has a 100% trademark registration rate, with 4 out of 4 resolved applications resulting in successful registration. Currently, 1 application is pending review.